Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03338946 · ClinicalTrials.gov registry record
Evaluation of CIED "Readers" for Disease Management
A clinical trial, sponsored by Edward Hospital.
- Completed
- Registry status
- 100
- Enrollment target
NCT03338946: Completed study, sponsored by Edward Hospital.
NCT03338946 is a clinical trial that has completed, run by Edward Hospital. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03338946 has completed, sponsored by Edward Hospital.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of remote interrogation (readers) of CIEDs in evaluation of suspected TIA/stroke patients, HF or those experiencing syncope. This approach has the potential to advance the practice of CIED evaluation by staff without specialized training in cardiac electrophysiology (non-EP staff). We hypothesize that actionable events will be identified with use of CIED readers. These events may include identification of atrial fibrillation in TIA/stroke patients, percentage biventricular pacing in patients with HF or evaluation of arrhythmic events in syncope patients. We believe that non-EP staff will find CIED readers easy or very easy to use and that time from transmission to analysis for non-EP trained staff will be low.
Primary Outcome
percent of those with events after reader review with actions such as admission/discharge, addition or change in medications, further testing
Interventions
- DEVICE CIED interrogation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-04-05 |
| Est. Completion | 2019-07-16 |
What the finished NCT03338946 record still lists
NCT03338946 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CIED interrogation is the first listed.
NCT03338946 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03338946 about?
NCT03338946 is a clinical study titled "Evaluation of CIED "Readers" for Disease Management". The purpose of this study is to evaluate the use of remote interrogation (readers) of CIEDs in evaluation of suspected TIA/stroke patients, HF or those experiencing syncope. This approach has the potential to advance the practice of CIED evaluation by staff without specialized training in cardiac el...
What is the current status of trial NCT03338946?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2018-04-05. Estimated completion is 2019-07-16.
What interventions are being tested in trial NCT03338946?
The interventions under investigation include: CIED interrogation (DEVICE).
Who is sponsoring clinical trial NCT03338946?
This trial is sponsored by Edward Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI